Cargando…
AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
Acute myeloid leukemia (AML) with myelodysplasia-related changes (AML-MRC) is a distinct biologic subtype of AML that represents 25–34% of all AML diagnoses and associates with especially inferior outcomes compared to non-MRC AML. Typically, patients with AML-MRC experience low remission rates follo...
Autores principales: | Koenig, Kristin L., Sahasrabudhe, Kieran D., Sigmund, Audrey M., Bhatnagar, Bhavana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464320/ https://www.ncbi.nlm.nih.gov/pubmed/32722092 http://dx.doi.org/10.3390/genes11080845 |
Ejemplares similares
-
Evaluating Blinatumomab for the Treatment of Relapsed/Refractory ALL: Design, Development, and Place in Therapy
por: Sigmund, Audrey M, et al.
Publicado: (2020) -
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
por: Lopes, Matheus Rodrigues, et al.
Publicado: (2017) -
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC)
por: Arber, Daniel A, et al.
Publicado: (2020) -
Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes
por: Bezerra, Matheus F., et al.
Publicado: (2022) -
Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)
por: Jacoby, Meagan A., et al.
Publicado: (2021)